| Unauthorized package |
1019584
|
ACT-HIB |
J07AG01 |
Haemophilus influenzae B, purified antigen conjugated |
powder and solvent for solution for injection |
10mcg 1TK |
Sanofi Pasteur SA |
Prescription |
|
|
müügiloata pakend |
|
|
 |
|
|
| Authorized package |
1659416
|
ADACEL |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection in pre-filled syringe |
0.5ml 10TK |
Sanofi Pasteur |
Prescription |
|
|
|
|
|
|
|
Yes |
| Unauthorized package |
1428195
|
ADACEL |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 1TK |
Sanofi Pasteur S.A. |
Prescription |
|
|
|
19.04.2013 |
|
|
|
|
| Unauthorized package |
1428207
|
ADACEL |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 10TK |
Sanofi Pasteur S.A. |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1659405
|
ADACEL |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection in pre-filled syringe |
0.5ml 1TK |
Sanofi Pasteur |
Prescription |
|
|
|
16.03.2023 |
|
|
|
Yes |
| Authorized package |
1451180
|
ADJUPANRIX |
J07BB02 |
Influenza, inactivated, split virus or surface antigen |
emulsion and suspension for emulsion for injection |
3,75mcg 0.5ml 5ml 50TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1506541
|
AFLUNOV |
J07BB02 |
Influenza, inactivated, split virus or surface antigen |
suspension for injection in pre-filled syringe |
7,5mcg 0.5ml 0.5ml 10TK |
Seqirus S.r.l. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1506530
|
AFLUNOV |
J07BB02 |
Influenza, inactivated, split virus or surface antigen |
suspension for injection in pre-filled syringe |
7,5mcg 0.5ml 0.5ml 1TK |
Seqirus S.r.l. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1208922
|
AMBIRIX |
J07BC80 |
Hepatitis A, inactivated, whole virus +Hepatitis B, purified antigen |
suspension for injection |
720ELISA ühik +20mcg 1ml 1TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1208933
|
AMBIRIX |
J07BC80 |
Hepatitis A, inactivated, whole virus +Hepatitis B, purified antigen |
suspension for injection |
720ELISA ühik +20mcg 1ml 10TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1208944
|
AMBIRIX |
J07BC80 |
Hepatitis A, inactivated, whole virus +Hepatitis B, purified antigen |
suspension for injection |
720ELISA ühik +20mcg 1ml 50TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1875135
|
APEXXNAR |
J07AL02 |
Pneumococcus, purified polysaccharides antigen conjugated |
suspension for injection |
1annus 0.5ml 1TK |
Pfizer Europe MA EEIG |
Prescription |
|
|
|
31.05.2023 |
|
|
|
Yes |
| Authorized package |
1875146
|
APEXXNAR |
J07AL02 |
Pneumococcus, purified polysaccharides antigen conjugated |
suspension for injection |
1annus 0.5ml 10TK |
Pfizer Europe MA EEIG |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1875157
|
APEXXNAR |
J07AL02 |
Pneumococcus, purified polysaccharides antigen conjugated |
suspension for injection |
1annus 0.5ml 50TK |
Pfizer Europe MA EEIG |
Prescription |
|
|
mitmikpakend |
|
|
|
|
Yes |
| Authorized package |
1024300
|
AVAXIM 160 U |
J07BC02 |
Hepatitis A, inactivated, whole virus |
suspension for injection in pre-filled syringe |
160ELISA ühik 0.5ml 0.5ml 1TK |
Sanofi Pasteur |
Prescription |
|
|
|
23.05.2023 |
|
|
|
Yes |
| Unauthorized package |
1684144
|
BCG VACCINE |
J07AN01 |
Tuberculosis, live attenuated |
powder and solvent for suspension for injection |
0,025mg 0.05ml 1ml 20TK |
BB-NCIPD Ltd. |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1042186
|
BCG VACCINE AJV |
J07AN01 |
Tuberculosis, live attenuated |
powder and solvent for suspension for injection |
0,75mg 10TK |
AJ Vaccines A/S |
Prescription |
|
|
lahusti 10 ml |
08.11.2022 |
|
|
|
Yes |
| Unauthorized package |
1852949
|
BCG VACCINE SSI |
J07AN01 |
Tuberculosis, live attenuated |
powder and solvent for suspension for injection |
0,75mg 10TK |
AJ Vaccines A/S |
Prescription |
|
|
müügiloata pakend |
|
|
|
|
|
| Unauthorized package |
1849989
|
BCG VACCINE SSI |
J07AN01 |
Tuberculosis, live attenuated |
powder and solvent for suspension for injection |
0,75mg 10TK |
Statens Serum Institut |
Prescription |
|
|
lahusti 10 ml |
|
|
|
|
|
| Unauthorized package |
1856527
|
BEXSERO |
J07AH09 |
Meningococcus B, multicomponent vaccine |
suspension for injection |
0,5ml 1annus 0.5ml 1TK |
Glaxosmithkline Vaccines S.r.l. |
Prescription |
|
|
müügiloata pakend |
|
|
|
|
|
| Authorized package |
1606092
|
BEXSERO |
J07AH09 |
Meningococcus B, multicomponent vaccine |
suspension for injection |
0,5ml 1annus 0.5ml 1TK |
Glaxosmithkline Vaccines S.r.l. |
Prescription |
|
|
|
17.02.2023 |
|
|
|
Yes |
| Authorized package |
1606104
|
BEXSERO |
J07AH09 |
Meningococcus B, multicomponent vaccine |
suspension for injection |
0,5ml 1annus 0.5ml 10TK |
Glaxosmithkline Vaccines S.r.l. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Unauthorized package |
1282823
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 25TK |
GlaxoSmithKline Eesti OÜ |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1282845
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection in pre-filled syringe |
1annus 0.5ml 1TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
eeltäidetud süstal |
11.04.2023 |
|
|
|
Yes |
| Unauthorized package |
1282799
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 1TK |
GlaxoSmithKline Eesti OÜ |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1282856
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection in pre-filled syringe |
1annus 0.5ml 10TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
eeltäidetud süstal |
|
|
|
|
Yes |
| Unauthorized package |
1282834
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 50TK |
GlaxoSmithKline Eesti OÜ |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1282801
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 10TK |
GlaxoSmithKline Eesti OÜ |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1282812
|
BOOSTRIX |
J07AX80 |
Diphtheria-tetanus-pertussis |
suspension for injection |
0.5ml 20TK |
GlaxoSmithKline Eesti OÜ |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1413087
|
CELVAPAN |
J07BB01 |
Influenza, inactivated, whole virus |
suspension for injection |
7,5mcg 0.5ml 5ml 20TK |
Nanotherapeutics Bohumil s.r.o. |
Prescription |
|
|
|
11.01.2010 |
|
|
|
|
| Authorized package |
1402906
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 1ml 1TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1312030
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 0.5ml 1TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
10.06.2009 |
|
|
|
Yes |
| Authorized package |
1312074
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 0.5ml 10TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
süstel |
|
|
|
|
Yes |
| Authorized package |
1402928
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 1ml 100TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1312041
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 0.5ml 10TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1312063
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 0.5ml 1TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
süstel |
23.02.2023 |
|
|
|
Yes |
| Authorized package |
1312052
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 0.5ml 100TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1402917
|
CERVARIX |
J07BM02 |
Human papillomavirus vaccine (types 16, 18) recombinant, adjuvanted, adsorbed |
suspension for injection |
1annus 0.5ml 1ml 10TK |
Glaxosmithkline Biologicals |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1834422
|
COMIRNATY |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
6annus 0.45ml 0.45ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
23.05.2022 |
|
|
|
Yes |
| Authorized package |
1864492
|
COMIRNATY |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1864481
|
COMIRNATY |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1865280
|
COMIRNATY (5-11 AASTAT) |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
10annus 1.3ml 1.3ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1865291
|
COMIRNATY (5-11 AASTAT) |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
10annus 1.3ml 1.3ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
24.10.2022 |
|
|
|
Yes |
| Authorized package |
1888959
|
COMIRNATY (6 KUUD- 4 AASTAT) |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
10annus 0.4ml 0.4ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1887947
|
COMIRNATY ORIGINAL/OMICRON BA.1 |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1887958
|
COMIRNATY ORIGINAL/OMICRON BA.1 |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
12.09.2022 |
|
|
|
Yes |
| Authorized package |
1888106
|
COMIRNATY ORIGINAL/OMICRON BA.4-5 |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1888117
|
COMIRNATY ORIGINAL/OMICRON BA.4-5 |
J07BN01 |
Covid-19, RNA-based vaccine |
dispersion for injection |
6annus 2.25ml 2.25ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
28.11.2022 |
|
|
|
Yes |
| Authorized package |
1889837
|
COMIRNATY ORIGINAL/OMICRON BA.4-5 (5-11 AASTAT) |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
10annus 1.3ml 1.3ml 195TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1889848
|
COMIRNATY ORIGINAL/OMICRON BA.4-5 (5-11 AASTAT) |
J07BN01 |
Covid-19, RNA-based vaccine |
concentrate for dispersion for injection |
10annus 1.3ml 1.3ml 10TK |
BioNTech Manufacturing GmbH |
Prescription |
|
|
|
28.11.2022 |
|
|
|
Yes |